Status:
RECRUITING
Clinical Application of Genetic Sequencing of Early Gastric Cancer and Gastric Adenoma Patients
Lead Sponsor:
Samsung Medical Center
Conditions:
Early Gastric Cancer
Gastric Adenoma
Eligibility:
All Genders
19-100 years
Brief Summary
Because advanced gastric cancer shows poor prognosis, it is important to detect early gastric cancer or precancerous gastric adenoma patients who have a cure rate of 95% or more. Moreover, a large par...
Detailed Description
1. Acquisition of tumor samples : Tissue and 10ml of blood will be collected for genomic examination of those histologically diagnosed with early gastric cancer or precancerous gastric adenoma lesion,...
Eligibility Criteria
Inclusion
- Those who are over the age of 19
- Those who were histologically confirmed with early gastric cancer or precancerous gastric adenoma
- Patients with early gastric cancer or precancerous gastric adenoma falling under the above criteria who have excess tissue stored from previous non-research purpose biopsy/endodoscopic removal for treatment and diagnosis
- Those whose life expectancy is more than 3 months
- Those who have voluntarily consented to participate in this clinical trial
Exclusion
- Those who will not yield enough samples
- Those who are considered inappropriate for this study in the discretion of the researchers
Key Trial Info
Start Date :
December 17 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2031
Estimated Enrollment :
1730 Patients enrolled
Trial Details
Trial ID
NCT04665687
Start Date
December 17 2020
End Date
December 31 2031
Last Update
September 12 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung medical center
Seoul, South Korea